ArticleGlycobiology2020

The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19.

Roger A LainePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.